FFCP PHASE1:Hg19::chr12:81172328..81172335,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:81172328..81172335,+ | |||
|coexpression_cluster_id=C21 | |||
|description=CAGE_peak_at_chr12:81172328..81172335,+ | |||
|id=chr12:81172328..81172335,+ | |||
|ontology_enrichment_celltype=CL:0000945!2.37e-30!24;CL:0000826!2.37e-30!24;CL:0000080!1.21e-18!6;CL:0000838!2.97e-17!52;CL:0000542!6.57e-17!53;CL:0000051!6.57e-17!53;CL:0000946!2.32e-13!1;CL:0000786!2.32e-13!1;CL:0000980!2.32e-13!1;CL:0000988!3.74e-09!182;CL:0002087!1.64e-08!119;CL:0002031!4.06e-08!124;CL:0000785!2.58e-07!2;CL:0000955!2.58e-07!2;CL:0000818!2.58e-07!2;CL:0000954!2.58e-07!2;CL:0000816!2.58e-07!2;CL:0000738!4.80e-07!140 | |||
|ontology_enrichment_celltype_v019=CL:0000946;3.67e-23;1!CL:0000786;3.67e-23;1!CL:0000945;6.17e-23;24!CL:0000542;9.06e-08;53 | |||
|ontology_enrichment_celltype_v019_2=CL:0000946,2.10e-23,1;CL:0000786,2.10e-23,1;CL:0000980,2.10e-23,1;CL:0000945,6.31e-23,24;CL:0000826,6.31e-23,24;CL:0000838,3.29e-15,52;CL:0000542,6.36e-15,53;CL:0000051,6.36e-15,53;CL:0000785,2.07e-12,2;CL:0000955,2.07e-12,2;CL:0000818,2.07e-12,2;CL:0000954,2.07e-12,2;CL:0000816,2.07e-12,2;CL:0000988,8.62e-10,177;CL:0000817,1.04e-08,3;CL:0002087,8.56e-07,115 | |||
|ontology_enrichment_development_v019=CL:0000954;2.74e-12;2!CL:0000051;9.06e-08;53 | |||
|ontology_enrichment_disease=DOID:0060060!1.82e-13!1;DOID:0060061!1.82e-13!1;DOID:8691!1.82e-13!1;DOID:4960!3.76e-13!1;DOID:0070004!3.76e-13!1;DOID:630!4.77e-13!1;DOID:0050177!4.77e-13!1;DOID:0050427!4.77e-13!1;DOID:2355!1.09e-12!1;DOID:0060058!4.78e-11!10;DOID:74!5.60e-07!2 | |||
|ontology_enrichment_disease_v019=DOID:0060060;1.33e-23;1!DOID:0060061;1.33e-23;1!DOID:8691;1.33e-23;1!DOID:4960;3.67e-23;1!DOID:0070004;3.67e-23;1 | |||
|ontology_enrichment_disease_v019_2=DOID:0060060,1.34e-23,1;DOID:0060061,1.34e-23,1;DOID:8691,1.34e-23,1;DOID:4960,5.13e-23,1;DOID:0070004,5.13e-23,1 | |||
|ontology_enrichment_uberon=UBERON:0002331!2.00e-11!10;UBERON:0000358!2.00e-11!10;UBERON:0000307!2.00e-11!10;UBERON:0000091!2.00e-11!10;UBERON:0000087!2.00e-11!10;UBERON:0007806!2.00e-11!10;UBERON:0008780!2.00e-11!10;UBERON:0005728!2.00e-11!10;UBERON:0000178!8.66e-08!15;UBERON:0000179!8.66e-08!15;UBERON:0000463!8.66e-08!15 | |||
|ontology_enrichment_uberon_v019=UBERON:0002331;1.33e-20;10!UBERON:0000178;5.51e-14;15!UBERON:0000179;5.51e-14;15!UBERON:0000463;5.51e-14;15!UBERON:0002390;3.18e-11;32!UBERON:0000478;5.50e-09;24 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002331,1.28e-20,10;UBERON:0000358,1.28e-20,10;UBERON:0000307,1.28e-20,10;UBERON:0000091,1.28e-20,10;UBERON:0000087,1.28e-20,10;UBERON:0007010,1.28e-20,10;UBERON:0007806,1.28e-20,10;UBERON:0008780,1.28e-20,10;UBERON:0005728,1.28e-20,10;UBERON:0000178,5.39e-14,15;UBERON:0000179,5.39e-14,15;UBERON:0000463,5.39e-14,15;UBERON:0000478,5.43e-09,24 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.840547463227464,1.47781061009902,1.02324015707783,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.605399502633369,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.511707249066704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.23084805461069,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.41302821701555,2.10058696209055,1.46190729307638,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0846733320657845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.110929051536852,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228840068396924,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.79969750051832,0,1.03328987796489,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.95897778844825,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0999411559249289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.961705476909699 | |||
|short_description=p@chr12:81172328..81172335,+ | |||
}} |
Latest revision as of 01:33, 25 September 2015
Short description: | p@chr12:81172328..81172335, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr12:81172328..81172335, + |
Coexpression cluster: | C21_cord_mycosis_hairy_xeroderma_adult_CD4_anaplastic |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
antibody secreting cell | 2.10e-23 | 1 |
plasma cell | 2.10e-23 | 1 |
plasmablast | 2.10e-23 | 1 |
lymphocyte of B lineage | 6.31e-23 | 24 |
pro-B cell | 6.31e-23 | 24 |
lymphoid lineage restricted progenitor cell | 3.29e-15 | 52 |
lymphocyte | 6.36e-15 | 53 |
common lymphoid progenitor | 6.36e-15 | 53 |
mature B cell | 2.07e-12 | 2 |
pre-B-II cell | 2.07e-12 | 2 |
transitional stage B cell | 2.07e-12 | 2 |
small pre-B-II cell | 2.07e-12 | 2 |
immature B cell | 2.07e-12 | 2 |
hematopoietic cell | 8.62e-10 | 177 |
precursor B cell | 1.04e-08 | 3 |
nongranular leukocyte | 8.56e-07 | 115 |
Ontology term | p-value | n |
---|---|---|
umbilical cord | 1.28e-20 | 10 |
blastocyst | 1.28e-20 | 10 |
blastula | 1.28e-20 | 10 |
bilaminar disc | 1.28e-20 | 10 |
inner cell mass | 1.28e-20 | 10 |
cleaving embryo | 1.28e-20 | 10 |
connecting stalk | 1.28e-20 | 10 |
inner cell mass derived epiblast | 1.28e-20 | 10 |
extraembryonic mesoderm | 1.28e-20 | 10 |
blood | 5.39e-14 | 15 |
haemolymphatic fluid | 5.39e-14 | 15 |
organism substance | 5.39e-14 | 15 |
extraembryonic structure | 5.43e-09 | 24 |
Ontology term | p-value | n |
---|---|---|
non-Hodgkin lymphoma | 1.34e-23 | 1 |
cutaneous T cell lymphoma | 1.34e-23 | 1 |
mycosis fungoides | 1.34e-23 | 1 |
bone marrow cancer | 5.13e-23 | 1 |
myeloma | 5.13e-23 | 1 |